Evernorth Holdings Inc. has officially received effectiveness for its S-1 registration, as detailed in a recent SEC filing. This development is crucial for the company as it seeks to raise capital and expand its operations.
Background
Evernorth Holdings Inc. is classified under the SIC code 6221, which pertains to Commodity Contracts Brokers & Dealers. The company trades on the Nasdaq under the tickers XRPN and XRPNW. Recent filings indicate that Evernorth is positioning itself strategically within the financial services sector.
What the Filing Says
The SEC filing, dated November 9, 2026, confirms the effectiveness of the S-1 registration. It states, "final effectiveness disp date: 2026-11-09" and indicates that the filing is live.
Impact
This filing may affect various stakeholders, including potential investors looking to engage with Evernorth's offerings. Additionally, competitors in the Commodity Contracts Brokers & Dealers sector may need to reassess their strategies in light of Evernorth's capital-raising initiatives.
What's Next
The filing does not say what happens next.
Company Information
Evernorth Holdings Inc. is incorporated in Nevada and operates under the EIN 394156999. The company's fiscal year ends on December 31, which may influence its financial reporting and strategic planning.
Contact Details
The business address for Evernorth Holdings Inc. is 600 Battery Street, San Francisco, CA 94111. Interested parties can reach the company by phone at 415-734-6959 for inquiries related to the S-1 registration and other corporate matters.
Filing Specifics
The filing is categorized under the SEC Act of 1933 and carries the SEC file number 333-299739. This classification indicates that the registration is intended for the public offering of securities, which is a critical step in the company's growth trajectory.
Additional Context
While the filing confirms the effectiveness of the S-1 registration, it does not provide specific details regarding the amount of capital Evernorth aims to raise or the intended use of proceeds from the offering. Such information would be vital for potential investors assessing the investment opportunity.
Read Next
Bowman Consulting Group announces effectiveness of filing
Silexion Therapeutics registers S-3 filing for capital raise
Bowman Consulting Group receives effectiveness for filing
Embraer S.A. Files Effect Notice with SEC for Compliance Update
Saba Capital Income & Opportunities Fund Registers Effectiveness
Terrestrial Energy Secures Effectiveness for SEC Filing










